Lifelong Learning Programme

This project has been funded with support from the European Commission.
This material reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein

Also available in:


Homepage > Databases > Publications


back to the list

Document Typology: Newspaper / Magazine article
Methodology addressed by the publication:Narrative medicine
Title of document: Inside MS
Name of author(s): Diana Rose
Name of publisher: Inside MS
Language of the publication: English
Language of the review: English
We have a lot to say about home in this issue. Starting with design principles that would make all homes more welcoming to humans of all shapes and sizes. "Universal Design" is not for people with disabilities; it is an approach to the built world that recognizes all sorts of temporary and permanent needs: the pregnant morn with a three-year-old in tow; the teenager with a leg fracture; the grandpa with arthritis in his hips; the person who weighs 295 lbs; the person who is 4'11" on tip toes or 6'10" in flat shoes.
But before the utopian future arrives when all design recognizes these realities, we're here trying to make a home. MS is very likely to change a family's requirements--starting with the urgent need to save energy for the good stuff. At the same time, finances may be pinched and options limited. Still, the questions are nearly universal. Can your home be safer? Can cleaning it be easier? Do adaptations have to look "medical" or threaten to devalue property? Do they have to cost the earth?
Reviewer's comments on the document:
Information provided by the National MS Society is based on professional advice, published experience, and expert opinion. Information provided in response to questions does not constitute therapeutic recommendations or prescriptions. The Society recommends that all questions and information be discussed with a personal physician.In the last couple of decades, nine new drugs have come on the market to treat M.S.; at least four more are currently being tested on humans. Few diseases have seen such radical transformation of treatment options in such a short time. Yet for all the new options, many of the 2.1 million people worldwide afflicted with the disease (400,000 of them in the United States) have not seen improvements, and some M.S. patients find that the adverse reactions from the drugs aren’t worth the benefits.
The various people I know who have restored their health after an "MS" diagnoses are those who avoid the medical industry and chose the rejuvenation and support of natural healing- through improved diet, bodywork, herbal therapeutics, movement therapeutics, and energy medicine. People can debate the allopathic medical issues all day long, but in the end their restored health speaks for itself.
Where to find it:

back to the list